Recurrence: all 3,523 studies

Page 13 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Medication Development in Alcoholism: Investigating Glucocorticoid AntagonistsCompletedNCT01548417Phase 2Results posted
• Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal CancerTerminatedNCT01545141Phase 1/2Results posted
• Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT01535924Phase 1/2Results posted
• Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSATerminatedNCT01531205Phase 2Results posted
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01529827Phase 2Results posted
• Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT01526928Phase 1/2Results posted
• Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsCompletedNCT01522469Phase 2Results posted
• Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)CompletedNCT01520922Phase 2Results posted
• Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.CompletedNCT01520870Phase 2Results posted
• GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic LeukemiaCompletedNCT01518517Phase 2/3Results posted
• Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1aCompletedNCT01514370Phase 2Results posted
• Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)TerminatedNCT01511081Phase 2Results posted
• Panitumumab and Bortezomib for Patients With Advanced Colorectal CancerTerminatedNCT01504477Phase 1/2Results posted
• Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic MalignanciesCompletedNCT01499147Not applicableResults posted
• Vinorelbine for Children With Progressive or Recurrent Low-grade GliomasCompletedNCT01497860Phase 2Results posted
• Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin LymphomaCompletedNCT01492088Phase 1/2Results posted
• Cetuximab and Dasatinib in Recurrent Squamous Cell CarcinomaTerminatedNCT01488318Phase 2Results posted
• A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic LeukemiaTerminatedNCT01486784Phase 1/2Results posted
• Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple MyelomaTerminatedNCT01484314Phase 2Results posted
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALLTerminatedNCT01483690Phase 1/2Results posted
• A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)CompletedNCT01482715Phase 1/2Results posted
• Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaCompletedNCT01471782Phase 1/2Results posted
• A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)CompletedNCT01466153Phase 2Results posted
• Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) AdultsCompletedNCT01462253Phase 2Results posted
• Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory NeuroblastomaCompletedNCT01460901Phase 1Results posted
• A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian CancersCompletedNCT01447706Phase 2Results posted
• Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaCompletedNCT01445080Phase 1/2Results posted
• Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)CompletedNCT01444742Phase 2Results posted
• Pomalidomide in Combination With High Dose Dexamethasone and Oral CyclophosphamideCompletedNCT01432600Phase 1/2Results posted
• Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesCompletedNCT01427881Phase 2Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerTerminatedNCT01420081Phase 2Results posted
• A Study of LY2523355 in Participants With Breast CancerCompletedNCT01416389Phase 2Results posted
• A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related TumorsCompletedNCT01413503Phase 2Results posted
• AC220 for Children With Relapsed/Refractory ALL or AMLCompletedNCT01411267Phase 1Results posted
• A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesCompletedNCT01384513Phase 2Results posted
• BIBF 1120 for Recurrent High-Grade GliomasCompletedNCT01380782Phase 2Results posted
• Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059)CompletedNCT01380184Phase 1Results posted
• Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple MyelomaCompletedNCT01380106Phase 2Results posted
• Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid UsersCompletedNCT01380093Phase 1Results posted
• Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort StudyCompletedNCT01360762Phase 3Results posted
• Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT01349049Phase 1/2Results posted
• Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade AstrocytomasTerminatedNCT01338857Phase 2Results posted
• Long-Term Safety and Efficacy Study of Peginterferon Beta-1aCompletedNCT01332019Phase 3Results posted
• Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT01326728Results posted
• Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple MyelomaCompletedNCT01324947Phase 3Results posted
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell TransplantCompletedNCT01321541Phase 3Results posted
• High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed NeuroblastomaCompletedNCT01313936Phase 1Results posted
• Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedNCT01313078Phase 2Results posted
• A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion StudyCompletedNCT01311687Phase 3Results posted
• Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantCompletedNCT01305200Phase 3Results posted
• Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)CompletedNCT01294579Phase 2Results posted
• Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01289522Phase 2Results posted
• Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic SyndromeCompletedNCT01289457Phase 1/2Results posted
• Memantine for Recurrent GlioblastomaTerminatedNCT01260467Phase 2Results posted
• Penicillin and Metronidazole in Treatment of Peritonsillar AbscessCompletedNCT01255670Not applicableResults posted
• Cognitive Training for Nicotine DependenceCompletedNCT01252966Not applicableResults posted
• GIMEMA CLL0809 Study (BendOfa)CompletedNCT01244451Phase 2Results posted
• The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS LymphomaTerminatedNCT01235793Phase 2Results posted
• AMG 102 and Erlotinib for Advanced Non-Small Cell Lung CancerCompletedNCT01233687Phase 1/2Results posted
• High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's DiseaseCompletedNCT01200329Phase 2Results posted
• Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)CompletedNCT01199575Phase 2Results posted
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)CompletedNCT01197560Phase 2/3Results posted
• The Long-term Value of Preoperative Duplex Before Surgery for Varicose VeinsCompletedNCT01195623Not applicableResults posted
• Typing of Human Papilloma Virus (HPV) From Female Genital WartsCompletedNCT01192282Results posted
• Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT01191190Phase 2Results posted
• Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or GefitinibTerminatedNCT01189435Phase 2Results posted
• Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal CancerCompletedNCT01188876Phase 1/2Results posted
• EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01186328Phase 1Results posted
• A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyCompletedNCT01184885Early Phase 1Results posted
• Trisenox® in Women With Metastatic Endometrial CancerTerminatedNCT01184053Phase 2Results posted
• Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple MyelomaCompletedNCT01177735Phase 2Results posted
• Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLLTerminatedNCT01173679Phase 2Results posted
• Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01173523Phase 2Results posted
• Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple MyelomaCompletedNCT01160484Phase 2Results posted
• Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive LeukemiaTerminatedNCT01158885Phase 2Results posted
• CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)CompletedNCT01134575Phase 2Results posted
• Cetuximab and Lenalidomide in Head and NeckCompletedNCT01133665Phase 2Results posted
• Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant RecipientsCompletedNCT01131065Phase 3Results posted
• A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBCompletedNCT01125800Phase 1/2Results posted
• Reducing Risk of RecurrenceCompletedNCT01122394Not applicableResults posted
• Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone LymphomaTerminatedNCT01121757Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted
• Comparing Non-fixation of Mesh to Mesh Fixation in Laparoscopic Inguinal Hernia RepairCompletedNCT01117337Phase 4Results posted
• AMG 102 and Avastin for Recurrent Malignant GliomaCompletedNCT01113398Phase 2Results posted
• Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)TerminatedNCT01090973Phase 2Results posted
• Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple MyelomaCompletedNCT01083602Phase 2Results posted
• Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral AntipsychoticsCompletedNCT01081769Phase 3Results posted
• Lichtenstein Patch or Prolene Hernia System (PHS) for Inguinal Hernia RepairCompletedNCT01070693Not applicableResults posted
• Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerActive, not recruitingNCT01068249Phase 2Results posted
• Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT01066663Phase 1/2Results posted
• Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease ActivityCompletedNCT01065571Not applicableResults posted
• Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.CompletedNCT01041508Phase 1Results posted
• EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01040832Phase 2Results posted
• Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric EpendymomaTerminatedNCT01032070Phase 2Results posted
• Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube CancerCompletedNCT01031381Phase 2Results posted
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple MyelomaCompletedNCT01023308Phase 3Results posted
• Radiosurgery and Avastin for Recurrent Malignant GliomasCompletedNCT01017250Not applicableResults posted
• Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell LymphomaCompletedNCT01014208Phase 3Results posted
• Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01001442Phase 1/2Results posted

← Recurrence overview